City of Hope Reports Novel Immunotherapy in Clinical Trial Shows Promise for Patients With Relapsed or Difficult to Treat Chronic Lymphocytic Leukemia
December 10, 2024
December 10, 2024
DUARTE, California, Dec. 10 (TNSres) -- City of Hope issued the following news release:
* * *
Epcoritamab study results reported today at American Society of Hematology's conference press briefing in San Diego
* * *
LOS ANGELES -- City of Hope, one of the largest and most advanced cancer research and treatment organizations in the United States, whose Los Angeles comprehensive cancer center is ranked among the nation's top five cancer centers . . .
* * *
Epcoritamab study results reported today at American Society of Hematology's conference press briefing in San Diego
* * *
LOS ANGELES -- City of Hope, one of the largest and most advanced cancer research and treatment organizations in the United States, whose Los Angeles comprehensive cancer center is ranked among the nation's top five cancer centers . . .